|Podcasts|January 21, 2022
M&A Milestones: The Covid Impact
Administrator on how pandemic has affected milestone events—the so-called “biodollars”—in life sciences’ deal structures
Advertisement
Casey McTigue, managing director of professional services at SRS Acquiom, which provides support for M&A transactions across various sectors, discusses the firm’s recently released study on milestone payment and earnout trends in life sciences M&A, including during Covid; their influence on sales and development milestones; how parties account for transaction disputes; and the potentially shifting power dynamic in pharma dealmaking post-pandemic.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How Specialty Growth and Cold Chain Demand Are Rewriting Distribution Strategy
2
Why Geopolitical Supply Chain Mapping Is Critical for Life Sciences
3
Commercial Trade's Expanding Mandate: From Product Movement to Commercial Performance
4
Mid-Year Check-In: Has Prior Auth Reform Delivered?
5